High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma

Robb Hollis*, Richard Elliott, John C Dawson, Narthana Ilenkovan, Rosie Matthews, Lorna Stillie, Ailsa Oswald, Hannah Kim, Marta Llaurado Fernandez, Michael Churchman, Joanna C Porter, Patricia Roxburgh, Asier Unciti-Broceta, David M Gershenson, C Simon Herrington, Mark S Carey, Neil O Carragher, Charlie Gourley

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science